203 related articles for article (PubMed ID: 30128866)
21. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
[TBL] [Abstract][Full Text] [Related]
22. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma.
Kusano N; Okita K; Shirahashi H; Harada T; Shiraishi K; Oga A; Kawauchi S; Furuya T; Sasaki K
Cancer; 2002 Feb; 94(3):746-51. PubMed ID: 11857308
[TBL] [Abstract][Full Text] [Related]
24. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
[TBL] [Abstract][Full Text] [Related]
25. Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
Brusselaers N; Ekwall K; Durand-Dubief M
Hum Genomics; 2019 Nov; 13(1):54. PubMed ID: 31699156
[TBL] [Abstract][Full Text] [Related]
26. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.
Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X
Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723
[TBL] [Abstract][Full Text] [Related]
27. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
[TBL] [Abstract][Full Text] [Related]
28. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
Schlaeger C; Longerich T; Schiller C; Bewerunge P; Mehrabi A; Toedt G; Kleeff J; Ehemann V; Eils R; Lichter P; Schirmacher P; Radlwimmer B
Hepatology; 2008 Feb; 47(2):511-20. PubMed ID: 18161050
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
30. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.
Kim TM; Yim SH; Shin SH; Xu HD; Jung YC; Park CK; Choi JY; Park WS; Kwon MS; Fiegler H; Carter NP; Rhyu MG; Chung YJ
Int J Cancer; 2008 Dec; 123(12):2808-15. PubMed ID: 18803288
[TBL] [Abstract][Full Text] [Related]
31. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
32. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
[TBL] [Abstract][Full Text] [Related]
33. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
34. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
Wang JL; Yan TT; Long C; Cai WW
Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
[TBL] [Abstract][Full Text] [Related]
37. [Expression of ATAD2 in different liver lesions and its clinical significance].
Liu F; Zhou X; Ji HH; Li H; Xiang FG
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):339-343. PubMed ID: 28763839
[No Abstract] [Full Text] [Related]
38. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.
Wang Y; Hu Y; Wu G; Yang Y; Tang Y; Zhang W; Wang K; Liu Y; Wang X; Li T
Oncotarget; 2017 May; 8(21):34429-34441. PubMed ID: 28415780
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]